Mostrar el registro sencillo del ítem
| dc.contributor.author | Murphy, Neil | |
| dc.contributor.author | Cross, Amanda-J | |
| dc.contributor.author | Riboli, Elio | |
| dc.contributor.author | Abubakar, Mustapha | |
| dc.contributor.author | Jenab, Mazda | |
| dc.contributor.author | Freisling, Heinz | |
| dc.contributor.author | Kong, So-Yeon | |
| dc.contributor.author | Muller, David-C | |
| dc.contributor.author | Gunter, Marc-J | |
| dc.contributor.author | Aleksandrova, Krasimira | |
| dc.contributor.author | Boutron-Ruault, Marie-Christine | |
| dc.contributor.author | Dossus, Laure | |
| dc.contributor.author | Racine, Antoine | |
| dc.contributor.author | Kuehn, Tilman | |
| dc.contributor.author | Katzke, Verena-A | |
| dc.contributor.author | Tjonneland, Anne | |
| dc.contributor.author | Petersen, Kristina-E-N | |
| dc.contributor.author | Overvad, Kim | |
| dc.contributor.author | Ramon-Quiros, J | |
| dc.contributor.author | Jakszyn, Paula | |
| dc.contributor.author | Molina-Montes, Esther | |
| dc.contributor.author | Dorronsoro, Miren | |
| dc.contributor.author | Huerta-Castaño, José-María | |
| dc.contributor.author | Barricarte, Aurelio | |
| dc.contributor.author | Khaw, Kay-Tee | |
| dc.contributor.author | Wareham, Nick | |
| dc.contributor.author | Travis, Ruth-C | |
| dc.contributor.author | Trichopoulou, Antonia | |
| dc.contributor.author | Lagiou, Pagona | |
| dc.contributor.author | Trichopoulos, Dimitrios | |
| dc.contributor.author | Masala, Giovanna | |
| dc.contributor.author | Krogh, Vittorio | |
| dc.contributor.author | Tumino, Rosario | |
| dc.contributor.author | Vineis, Paolo | |
| dc.contributor.author | Panico, Salvatore | |
| dc.contributor.author | Siersema, Peter-D | |
| dc.contributor.author | Bueno-de-Mesquita, H-Bas | |
| dc.contributor.author | Peeters, Petra-H | |
| dc.contributor.author | Ohlsson, Bodil | |
| dc.contributor.author | Ericson, Ulrika | |
| dc.contributor.author | Palmqvist, Richard | |
| dc.contributor.author | Nystrom, Hanna | |
| dc.contributor.author | Skeie, Guri | |
| dc.contributor.author | Weiderpass, Elisabete | |
| dc.contributor.author | Tsilidis, Kostas | |
| dc.date.accessioned | 2026-10-21T06:19:56Z | |
| dc.date.available | 2026-10-21T06:19:56Z | |
| dc.date.issued | 2016-04-05 | |
| dc.identifier.citation | Murphy N, Cross AJ, Abubakar M, Jenab M, Aleksandrova K, Boutron-Ruault MC, et al. A Nested Case-Control Study of Metabolically Defined Body Size Phenotypes and Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). Beck AH, editor. PLoS Med. 5 de abril de 2016;13(4):e1001988. doi:10.1371/journal.pmed.1001988 | |
| dc.identifier.issn | 1549-1277 | |
| dc.identifier.uri | https://sms.carm.es/ricsmur/handle/123456789/28884 | |
| dc.description.abstract | BACKGROUND: Obesity is positively associated with colorectal cancer. Recently, body size subtypes categorised by the prevalence of hyperinsulinaemia have been defined, and metabolically healthy overweight/obese individuals (without hyperinsulinaemia) have been suggested to be at lower risk of cardiovascular disease than their metabolically unhealthy (hyperinsulinaemic) overweight/obese counterparts. Whether similarly variable relationships exist for metabolically defined body size phenotypes and colorectal cancer risk is unknown. METHODS AND FINDINGS: The association of metabolically defined body size phenotypes with colorectal cancer was investigated in a case-control study nested within the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Metabolic health/body size phenotypes were defined according to hyperinsulinaemia status using serum concentrations of C-peptide, a marker of insulin secretion. A total of 737 incident colorectal cancer cases and 737 matched controls were divided into tertiles based on the distribution of C-peptide concentration amongst the control population, and participants were classified as metabolically healthy if below the first tertile of C-peptide and metabolically unhealthy if above the first tertile. These metabolic health definitions were then combined with body mass index (BMI) measurements to create four metabolic health/body size phenotype categories: (1) metabolically healthy/normal weight (BMI < 25 kg/m2), (2) metabolically healthy/overweight (BMI ? 25 kg/m2), (3) metabolically unhealthy/normal weight (BMI < 25 kg/m2), and (4) metabolically unhealthy/overweight (BMI ? 25 kg/m2). Additionally, in separate models, waist circumference measurements (using the International Diabetes Federation cut-points [?80 cm for women and ?94 cm for men]) were used (instead of BMI) to create the four metabolic health/body size phenotype categories. Statistical tests used in the analysis were all two-sided, and a p-value of <0.05 was considered statistically significant. In multivariable-adjusted conditional logistic regression models with BMI used to define adiposity, compared with metabolically healthy/normal weight individuals, we observed a higher colorectal cancer risk among metabolically unhealthy/normal weight (odds ratio [OR] = 1.59, 95% CI 1.10-2.28) and metabolically unhealthy/overweight (OR = 1.40, 95% CI 1.01-1.94) participants, but not among metabolically healthy/overweight individuals (OR = 0.96, 95% CI 0.65-1.42). Among the overweight individuals, lower colorectal cancer risk was observed for metabolically healthy/overweight individuals compared with metabolically unhealthy/overweight individuals (OR = 0.69, 95% CI 0.49-0.96). These associations were generally consistent when waist circumference was used as the measure of adiposity. To our knowledge, there is no universally accepted clinical definition for using C-peptide level as an indication of hyperinsulinaemia. Therefore, a possible limitation of our analysis was that the classification of individuals as being hyperinsulinaemic-based on their C-peptide level-was arbitrary. However, when we used quartiles or the median of C-peptide, instead of tertiles, as the cut-point of hyperinsulinaemia, a similar pattern of associations was observed. CONCLUSIONS: These results support the idea that individuals with the metabolically healthy/overweight phenotype (with normal insulin levels) are at lower colorectal cancer risk than those with hyperinsulinaemia. The combination of anthropometric measures with metabolic parameters, such as C-peptide, may be useful for defining strata of the population at greater risk of colorectal cancer. | |
| dc.language.iso | eng | |
| dc.rights | Atribución/Reconocimiento 4.0 Internacional | |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/deed.es | * |
| dc.subject.mesh | Adiposity | |
| dc.subject.mesh | Biomarkers/blood | |
| dc.subject.mesh | Body Mass Index | |
| dc.subject.mesh | Body Size | |
| dc.subject.mesh | C-Peptide/blood | |
| dc.subject.mesh | Case-Control Studies | |
| dc.subject.mesh | Chi-Square Distribution | |
| dc.subject.mesh | Colorectal Neoplasms/diagnosis/epidemiology | |
| dc.subject.mesh | Europe/epidemiology | |
| dc.subject.mesh | Female | |
| dc.subject.mesh | Health Status | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Hyperinsulinism/blood/diagnosis/epidemiology | |
| dc.subject.mesh | Incidence | |
| dc.subject.mesh | Logistic Models | |
| dc.subject.mesh | Male | |
| dc.subject.mesh | Middle Aged | |
| dc.subject.mesh | Multivariate Analysis | |
| dc.subject.mesh | Obesity/blood/diagnosis/epidemiology | |
| dc.subject.mesh | Obesity, Metabolically Benign/blood/diagnosis/epidemiology | |
| dc.subject.mesh | Odds Ratio | |
| dc.subject.mesh | Phenotype | |
| dc.subject.mesh | Prospective Studies | |
| dc.subject.mesh | Protective Factors | |
| dc.subject.mesh | Risk Assessment | |
| dc.subject.mesh | Risk Factors | |
| dc.subject.mesh | Waist Circumference | |
| dc.title | A Nested Case-Control Study of Metabolically Defined Body Size Phenotypes and Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) | |
| dc.type | info:eu-repo/semantics/article | |
| dc.identifier.pmid | 27046222 | |
| dc.relation.publisherversion | https://dx.plos.org/10.1371/journal.pmed.1001988 | |
| dc.identifier.doi | 10.1371/journal.pmed.1001988 | |
| dc.journal.title | Plos Medicine | |
| dc.identifier.essn | 1549-1676 |